ScholarIQanswers from OpenAlex
Neurofibromatosis Therapeutic Acceleration Program
FunderResearch funding and supported work
Neurofibromatosis Therapeutic Acceleration Program is a funder indexed in ScholarIQ from OpenAlex.
How many works does Neurofibromatosis Therapeutic Acceleration Program have?
ScholarIQindexed works
Neurofibromatosis Therapeutic Acceleration Program has 122 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
What is the OpenAlex record for Neurofibromatosis Therapeutic Acceleration Program?
ScholarIQopenalex
The OpenAlex for Neurofibromatosis Therapeutic Acceleration Program is on the source record.
What are the most-cited papers on Neurofibromatosis Therapeutic Acceleration Program?
ScholarIQmost cited works
A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib
Millicent S. Curlee, Mary Anne Toledo‐Tamula, Melissa Baker, Daniel Wikstrom, Cynthia Harrison, Amanda Rhodes, Margaret Fagan, Cecilia Tibery, Pamela L. Wolters, Brigitte C. Widemann, Andrea M. Gross, Staci Martin